Official AMFI data
Arthkar — Understand Money, Invest Smartly

Listed equity

Windlas Biotech

NSE: WINDLASBSE: 543329M-cap ₹2.1K Cr2 mutual funds hold this
₹982.45▼₹3.70(-0.63%)

EOD close · 19 Nov 2026

consolidationaccumulation +26Quiet accumulation · 6d

Range-bound — awaiting direction.

52W low ₹699.3552W high ₹1181.00

Now at 57% of its 52-week range

Last 30 sessions

-8.9%

Phase indicator

consolidation-17.4% from 52w high

Range-bound — awaiting direction.

1M
+8.6%
3M
+2.0%
1Y
+20.8%

Delivery conviction

accumulationscore +26
Delivery vs 20-day avg1.15x
Buy / sell pressure89.0% buy
Quiet accumulation active for 6 consecutive days. See full screener

Lifetime story

Windlas Biotech is up 383.6% from its lifetime low of ₹203.15 on 20 Jun 2022. ₹10,000 invested then would be worth ₹48,361 today (42.9% CAGR over 4.4 years). Lifetime high of ₹1197.00 was set on 6 Nov 2024 (currently -17.9% below).

30-day conviction trend

22 Sept 202619 Nov 2026

Fundamentals

Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.

43% cheaper than industry(Industry P/E 54.3)
StandaloneConsolidated
P/E (TTM)31.0031.11
P/B3.463.56
Price / Cash flow21.2221.27
Dividend yield0.64%0.64%
Book value / share285.12 ₹276.72 ₹
EPS (TTM)31.77 ₹31.66 ₹
Market cap
₹2.1K Cr
52W high
₹1181.00
7 Sept 2026
52W low
₹699.35
16 Mar 2026

Returns ladder

1W
-2.7%
1M
+8.6%
3M
+2.0%
6M
+28.1%
YTD
+23.9%
1Y
+20.8%
3Y
+134.3%
5Y
+234.2%
10Y
—
Since listing
+142.2%

Disclosed to the exchange

Large trades in Windlas Biotech

Single large transactions, named by NSE the same evening. No mutual fund appears in this window.

latest 6 Nov 2026

  • 6 Nov 2026
    BUYSTELLAR WEALTH PARTNERS INDIA FUND I LP
    bulk1,50,500₹1020.42₹15.4 Cr

Source: NSE bulk and block deal disclosures, reproduced as reported. A deal is disclosed only when one party trades at least 0.5% of a company's shares in a day, or negotiates a block of ₹25 crore or more — so most institutional activity never appears here, and a stock with no rows has not necessarily been left alone. Where a trade qualified as both, it is shown once carrying both labels. NSE names the fund house, never the scheme, so no individual fund can be inferred from these rows. Value is quantity × the reported price, which for a bulk deal is a weighted average.

How this page is produced

Every figure above is computed from end-of-day exchange prices, snapshotted daily, closing 19 Nov 2026. Nothing here is copied from a factsheet or a third-party summary. The full method is published, including its limitations.

Prices are end-of-day closes, not live quotes, and are not intended for trading decisions.

Written and maintained by Azad Mohammed, who built the pipeline these numbers come out of. Found an error? Tell us — corrections are made and the page rebuilds within the hour.

This page describes what has already happened. It is not investment advice and not a recommendation to buy or sell any security. Arthkar is not a SEBI-registered investment adviser or research analyst, and does not provide or arrange investment advice. Investments in securities are subject to market risk.